Article
What's R&D Got To Do With It?
December 21, 2011
By Cliff Mintz Ph.D., Life Science Leader magazine
Over the last five years or so, many big pharmaceutical companies concluded that their internal R&D activities were no longer delivering the ROI they had grown to expect. This resulted in the elimination of hundreds of thousands of jobs and the outsourcing of many R&D activities. While most executives and industry insiders believe that downsizing and outsourcing R&D is a sound idea, John LaMattina, Ph.D., former senior VP at Pfizer and president of Pfizer Global R&D, who spent 30 years in R&D after joining the company in 1977, is not so sure.
Used with permission from Life Science Leader magazine.
The content you requested is only available to registered users of Bioresearch Online. By registering now, you'll get exclusive access to this piece of content and thousands of addtional articles and product reviews across our entire network of sites.
